|
|
||||||||
-agonists in SERCA1a-expressing
hearts ex vivo and in vivo
1 Department of Physiology and Cell Biology, Ohio State University College of Medicine and Public Health, Columbus 43210; and Departments of 2 Molecular and Cellular Physiology and 3 Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
H965, 2002; 10.1152/ajpheart.00078.2002.
In this study we
evaluated the contractile characteristics of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)1a-expressing hearts ex vivo
and in vivo and in particular their response to
-adrenergic
stimulation. Analysis of isolated, work-performing hearts revealed that
transgenic (TG) hearts develop much higher maximal rates of contraction
and relaxation than wild-type (WT) hearts. Addition of isoproterenol
only moderately increased the maximal rate of relaxation (+20%) but
did not increase contractility or decrease relaxation time in TG
hearts. Perfusion with varied buffer Ca2+ concentrations
indicated an altered dose response to Ca2+. In vivo TG
hearts displayed fairly higher maximal rates of contraction (+ 25%)
but unchanged relaxation parameters and a blunted but significant
response to dobutamine. Our study also shows that the phospholamban
(PLB) level was decreased (
40%) and its phosphorylation status
modified in TG hearts. This study clearly demonstrates that increases
in SERCA protein level alter the
-adrenergic response and affect the
phosphorylation of PLB. Interestingly, the overall cardiac function in
the live animal is only slightly enhanced, suggesting that
(neuro)hormonal regulations may play an important role in controlling
in vivo heart function.
transgenic mice; contractility; sarco(endo)plasmic reticulum calcium adenosinetriphosphatase; phospholamban
This article has been cited by other articles:
![]() |
J. M. O'Donnell, A. Fields, X. Xu, S. A. K. Chowdhury, D. L. Geenen, and J. Bi Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2483 - H2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. H. Talukder, A. Kalyanasundaram, X. Zhao, L. Zuo, P. Bhupathy, G. J. Babu, A. J. Cardounel, M. Periasamy, and J. L. Zweier Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2418 - H2428. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |